Innovation

The ‘blue screen of death’ descended on computers around the world on Friday. Here are the immediate, short, and long-term things you can do to ensure your system is up and running.

The firm at the heart of the global IT outage was created to ‘reinvent security for the cloud era,’ according to company documents. It is headquartered in Austin, Texas, listed on NASDAQ, and is valued at $124 billion.

Woolworths, ABC, Telstra, The Australian, and are among the companies that have been impacted. Sydney Airport confirmed technical outages today. US airlines Frontier, Allegiant and SunCountry also reported their operations have been impacted due to outages.

At least 12.9 million Australians had their data stolen in the MediSecure hack earlier this year. But the eScripts provider now says it is unable to identify specific individuals affected in what is one of the largest breaches in the nation’s history.

In 2019, Sadi Khan founded Aven. Five years on, it has hit a $1 billion valuation and is backed by big-name investors. But is it a good idea?

After selling Candy Crush developer for $5.9 billion, one cofounder Sebastian Knutsson has a new gaming startup.

Apple can generate a whopping $485 billion in iPhone revenues over the next two years as users upgrade to AI-enabled devices, according to Morgan Stanley analyst projections.

An Australian firm is revolutionising carbon capture in the cement, steel, power generation, and chemical production industries. KC8 received $10m in funding from Woodside Energy and Mexico’s Cemex Ventures.

Chris Kirchner was arrested in 2023 following a Forbes investigation that revealed he overstated company financials and spent lavishly on personal expenses.

A class of diabetes and weight loss drugs that includes Novo Nordisk’s Ozempic and Eli Lilly’s Mounjaro could also help protect against a variety of cancers, according to new research published Friday, adding to mounting evidence that injections offer numerous additional health benefits as pressure builds for insurers and public health providers to cover the popular medication in spite of persistent shortages and cost concerns.